Floatz logo

HUMAN FAECAL MATTER

Obesity; Familial

Federal Research and Clinical Center of Physical-Chemical Medicineother_biologicalN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Obesity; Familial cohort.

Asset / SponsorPhaseRating
Setmelanotide
Rhythm Pharmaceuticals, Inc.
Phase 3BBB
Mibavademab
Regeneron Pharmaceuticals
Phase 3B
Semaglutide
Prof. Dr. Martin Wabitsch
D
IMMUNOGLOBULIN G4 (227-PROLINE), ANTI-(HUMAN LEPTIN RECEPTOR) (HUMAN MONOCLONAL REGN4461 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN4461 .KAPPA.-CHAIN, DIMER
D

Same molecule, other indications

HUMAN FAECAL MATTER is also rated in:

cirrhosis of liverDormant
BB
Indicative ·
66 / 100
View asset →
hepatic encephalopathyDormant
B
Indicative ·
61 / 100
View asset →
metabolic dysfunction-associated steatohepatitisDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →